LR Health & Beauty SE confirms growth trend in the second quarter of 2024 Sales increased to EUR 143.3 million in the first half of 2024   Normalized EBITDA of EUR 14.4 million Rising demand for subscription concepts like the successful LR Health Mission Growth prospects strengthened by innovative product range and planned launch of a new p [ … ]

LR Health & Beauty SE delivers good start into the 2024 financial year Sales of EUR 72.6 million in the first quarter of 2024 Normalised EBITDA of EUR 7.8 million Focus on further expansion of innovative product range Digital initiatives progressing successfully Ahlen, 28 May 2024 – LR Health & Beauty SE, Europe’s leading digital social [ … ]

LR Health & Beauty SE delivers good start into the 2024 financial year Sales of EUR 72.6 million in the first quarter of 2024 Normalised EBITDA of EUR 7.8 million Focus on further expansion of innovative product range Digital initiatives progressing successfully Ahlen, 28 May 2024 – LR Health & Beauty SE, Europe’s leading digital social [ … ]

LR Health & Beauty SE reports a successful 2023 financial year and expands its innovative product range Sales increase to EUR 276.5 million; EBITDA reported reaches EUR 31.4 million Digitalisation and sales activities promote partners’ career development Expansion of innovative product range provides for positive business outlook  Ahlen, 30  [ … ]

LR Health & Beauty SE: Shareholder Quadriga Capital wins Evoco as major investor / Investors provide additional capital to fund successful growth strategy Quadriga Capital wins Evoco as major investor for LR Health & Beauty Investors support successful growth strategy with additional capital Settlement of New Bond 2024/2028 completed  Ah [ … ]